Combined treatment of disfiguring facial angiofibromas in tuberous sclerosis complex with surgical debulking and topical sirolimus

Cutis. 2020 Dec;106(6):307-308. doi: 10.12788/cutis.0137.

Abstract

Tuberous sclerosis complex (TSC) is an autosomal-dominant disorder that causes the formation of hamartomatous tumors such as facial angiofibromas (FAs). We present a combination of surgical debulking via shave biopsy, curettage, and electrocautery followed by application of sirolimus ointment 1% to the nose to treat FAs in the setting of TSC. This novel approach achieved an optimal therapeutic response in our patient with minimal recurrence of FAs after 1 year of follow-up.

MeSH terms

  • Angiofibroma* / drug therapy
  • Cytoreduction Surgical Procedures
  • Facial Neoplasms* / drug therapy
  • Humans
  • Neoplasm Recurrence, Local
  • Sirolimus / therapeutic use
  • Tuberous Sclerosis* / complications

Substances

  • Sirolimus